Evaluation of Hyperemia With the Use of Ocular Prostaglandin Analogues

Study Identifier
MA-LUM-07-003
CT.gov Identifier
NCT00539526
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Glaucoma - Open Angle
  • Ocular Hypertension
    • Study Drug
  • Bimatoprost 0.03%
  • travoprost 0.004%
  • latanoprost 0.005% eye drops
    • Phase
    Phase 4
    Sex
    Female & Male
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Diagnosis of open-angle glaucoma (pseudoexfoliative or pigmentary glaucomas are allowed) or ocular hypertension
    Exclusion Criteria:
    * Known contraindication to latanoprost, bimatoprost or travoprost * Uncontrolled systemic disease * Active ocular disease other than glaucoma or ocular hypertension * Pregnant or lactating women or women of childbearing potential NOT utilizing a medically acceptable form of birth control

    Protocol Summary

    This study will evaluate hyperemia and ocular surface tolerability in patients on prostaglandin analogues

    Study Locations

    Location
    Status
    Location
    San Diego, California, United States
    Status
    Not applicable